Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Ji Young | - |
dc.contributor.author | Rha, Seung-Woon | - |
dc.contributor.author | Choi, ByoungGeol | - |
dc.contributor.author | Choi, Jae Woong | - |
dc.contributor.author | Ryu, Sung Kee | - |
dc.contributor.author | Kim, Seunghwa | - |
dc.contributor.author | Noh, Yung-Kyun | - |
dc.contributor.author | Choi, Se Yeon | - |
dc.contributor.author | Akkala, Raghavender Goud | - |
dc.contributor.author | Li, Hu | - |
dc.contributor.author | Ali, Jabar | - |
dc.contributor.author | Xu, Shaopeng | - |
dc.contributor.author | Ngow, Harris Abdullah | - |
dc.contributor.author | Lee, Jae Joong | - |
dc.contributor.author | Lee, Gwang No) | - |
dc.contributor.author | Kim, JiBak | - |
dc.contributor.author | Lee, Sunki | - |
dc.contributor.author | Na, Jin Oh | - |
dc.contributor.author | Choi, Cheol Ung | - |
dc.contributor.author | Lim, Hong Euy | - |
dc.contributor.author | Kim, Jin Won | - |
dc.contributor.author | Kim, Eungju | - |
dc.contributor.author | Park, Chang Gyu | - |
dc.contributor.author | SeogSeo, Hong | - |
dc.contributor.author | Oh, Dong Joo | - |
dc.date.accessioned | 2022-07-16T00:51:13Z | - |
dc.date.available | 2022-07-16T00:51:13Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 0167-5273 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/158053 | - |
dc.description.abstract | Background High dose atorvastatin is known to be associated with new onset diabetes mellitus (NODM) in patients with high risk for developing diabetes mellitus (DM). However, low dose atorvastatin is more commonly used as compared with high dose atorvastatin. The aim of this study is to investigate the impact of low dose atorvastatin (LDA, 10 mg or 20 mg) on the development of NODM up to three years in Asian patients. Methods From January 2004 to September 2009, we investigated a total of 3566 patients who did not have DM. To adjust for potential confounders, a propensity score matching (PSM) analysis was performed using the logistic regression model. After PSM (C-statistics: 0.851), a total of 818 patients (LDA group, n = 409 patients and control group, n = 409 patients) were enrolled for analysis. Results Before PSM, the cumulative incidence of NODM (5.8% vs. 2.1%, p < 0.001), myocardial infarction (0.5% vs. 0.1%, p-value = 0.007), and major adverse cardio-cerebral event (MACCE, 1.8% vs. 0.7%, p-value = 0.012) at three-years were higher in the LAD group. However, after PSM, there was a trend toward higher incidence of NODM (5.9% vs. 3.2%, p = 0.064) in the LDA group, but the incidence of MACCE (1.2% vs. 1.5%, p-value = 1.000) was similar between the two groups. In multivariable analysis, the LDA administration was tended to be an independent predictor of NODM (OR: 1.99, 95% CI: 1.00–3.98, p-value 0.050). Conclusions In this study, the use of LDA tended to be a risk factor for NODM in Asian patients and reduced clinical events similar to the control group. However, large-scale randomized controlled trials will be needed to get the final conclusion. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.title | Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Noh, Yung-Kyun | - |
dc.identifier.doi | 10.1016/j.ijcard.2015.03.047 | - |
dc.identifier.scopusid | 2-s2.0-84933556998 | - |
dc.identifier.wosid | 000353763800118 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CARDIOLOGY, v.184, no.1, pp.502 - 506 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CARDIOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CARDIOLOGY | - |
dc.citation.volume | 184 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 502 | - |
dc.citation.endPage | 506 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | diuretic agent | - |
dc.subject.keywordPlus | atorvastatin | - |
dc.subject.keywordPlus | glucose blood level | - |
dc.subject.keywordPlus | hypocholesterolemic agent | - |
dc.subject.keywordAuthor | Atorvastatin | - |
dc.subject.keywordAuthor | New onset diabetes mellitus | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0167527315002855?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.